Last Updated:
Access Report
Name Designation Appointment Date Status
Rajavarshan Ramamoorthy

Appointed as Additional Director since March 2021

 Additional Director 04-Mar-2021 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Loga Ranjan Divya Sri

Appointed as Director since August 2016

 Director 09-Aug-2016 Current

People Timeline

Explore the timeline of key personnel in V S Clinical Research And Hospitals Private Limited's leadership journey.

Contact Details
  • Address 8A Ambica Cross Street Velachery, Chennai Tamil Nadu, 600042, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 600042
  • Country India
  • Website -
Frequently Asked Questions
How can I contact V S Clinical Research And Hospitals Private Limited?
You can contact V S Clinical Research And Hospitals Private Limited through their registered address at 8A Ambica Cross Street Velachery, Chennai Tamil Nadu, 600042, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of V S Clinical Research And Hospitals Private Limited?
The current directors of V S Clinical Research And Hospitals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • RAJAVARSHAN RAMAMOORTHY
  • LOGA RANJAN DIVYA SRI
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available